SECOND GENOME, INC.

Profile

Company Names

SECOND GENOME, INC.

Addresses

1700 OWENS ST, 5TH FL, SAN FRANCISCO, CA 94158

Phone Numbers

888-666-0859

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$4,999,999.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-07-26 
$4,999,999.00 
$4,999,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
CARUSI 
DIRECTOR
ENDOGASTRIC SOLUTIONS INC   |  GI DYNAMICS, INC.   |  POWERVISION, INC.   |  GLUMETRICS INC   |  ALTURA MEDICAL, INC.   |  SECOND GENOME, INC.   |  EXPLORAMED NC7, INC.   |  TALLAC THERAPEUTICS, INC.   |  MEDISIX THERAPEUTICS, INC.   |  CALA HEALTH, INC.   |  WILLOW INNOVATIONS, INC.
PETER 
 
DILAURA 
EXECUTIVE OFFICER, DIRECTOR
SECOND GENOME, INC.   |  NAKED BIOME, INC.   |  CHARACTER BIOSCIENCES, INC.
PETER 
 
GARDNER 
DIRECTOR
WAVEPOINT PARTNERS II, L.P.   |  CLOUD CRUISER INC   |  SECOND GENOME, INC.
COREY 
 
GOODMAN 
DIRECTOR
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
JASON 
 
LETTMANN 
DIRECTOR
SECOND GENOME, INC.   |  RELIEVANT MEDSYSTEMS, INC.
MATTHEW 
 
WINKLER 
DIRECTOR
SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  AKOYA BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-08-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#